NCT01925547
- Conditions
- Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +4 more
- Locations
-
- Institute of Biological Chemistry and Nutrition, University of Hohenheim Stuttgart, Baden-Wurttemberg, Germany
Clinical trial condition
Hyperinsulinism
Explore clinical trials studying Hyperinsulinism. Study availability and eligibility vary by location and protocol.
3,690 public trials
357 recruiting studies
Hyperinsulinism trial results
NCT02358109
- Conditions
- Behavior, Cardiovascular Diseases, Diabetes, +12 more
- Locations
-
- Department of Physiology, Faculty of Farmacy, University of Granada Granada, Andalusia, Spain
NCT02852044
- Conditions
- Glucose Metabolism Disorders, Hyperglycemia, Hyperinsulinism, +4 more
- Locations
-
- Department for Health, University of Bath Bath, United Kingdom
Completed
Effect of resVida on Liver Fat Content
NCT01635114
- Conditions
- Elevated Liver Fat Content and Insulin Resistance, Glucose Metabolism Disorders, Hyperinsulinism, +3 more
- Locations
-
- University Hospital Tuebingen Tübingen, Germany
NCT01879891
- Conditions
- Glucose Metabolism Disorders, Healthy Women, Hyperinsulinism, +3 more
- Locations
-
- UAB Birmingham, Alabama, United States
NCT02942732
- Conditions
- Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +2 more
- Locations
-
Not specified
Completed
Diet and Metabolic Inflammation
NCT02539355
- Conditions
- Body Weight, Cancer, Diabetes, +16 more
- Locations
-
- Fred Hutchinson Cancer Research Center Seattle, Washington, United States
NCT02227628
- Conditions
- Body Weight, Cardiovascular Disease, Cardiovascular Diseases, +12 more
- Locations
-
- Exercise & Sport Nutrition Laboratory (ESNL) in the Department of Health and Kinesiology at Texas A&M University College Station, Texas, United States
NCT00866658
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +6 more
- Locations
-
- Sanofi-Aventis Administrative Office Tokyo, Japan
- Sanofi-Aventis Administrative Office Makati City, Philippines
- Sanofi-Aventis Administrative Office Seoul, South Korea
- Sanofi-Aventis Administrative Office Taipei, Taiwan
NCT01856946
- Conditions
- Glucose Metabolism Disorders, Hyperinsulinism, Insulin Resistance, +2 more
- Locations
-
- University of Missouri Adolescent Obesity Clinic Columbia, Missouri, United States